Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to 0.86.

  • Iradimed's Equity Ratio fell 315.71% to 0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86, marking a year-over-year decrease of 315.71%. This contributed to the annual value of 0.88 for FY2024, which is 1393.3% up from last year.
  • Iradimed's Equity Ratio amounted to 0.86 in Q3 2025, which was down 315.71% from 0.89 recorded in Q2 2025.
  • In the past 5 years, Iradimed's Equity Ratio ranged from a high of 0.89 in Q2 2025 and a low of 0.77 during Q4 2023
  • Over the past 5 years, Iradimed's median Equity Ratio value was 0.87 (recorded in 2021), while the average stood at 0.86.
  • Per our database at Business Quant, Iradimed's Equity Ratio tumbled by 1004.52% in 2023 and then skyrocketed by 1393.3% in 2024.
  • Quarter analysis of 5 years shows Iradimed's Equity Ratio stood at 0.87 in 2021, then dropped by 1.07% to 0.86 in 2022, then dropped by 10.05% to 0.77 in 2023, then grew by 13.93% to 0.88 in 2024, then decreased by 2.91% to 0.86 in 2025.
  • Its last three reported values are 0.86 in Q3 2025, 0.89 for Q2 2025, and 0.89 during Q1 2025.